本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Correvio Pharma Corp.

0.4199
0.0000
成交量:- -
成交额:- -
市值:2,779.38万
市盈率:-0.53
高:0.4199
开:0.4199
低:0.4199
收:0.4199
数据加载中...
2020/05/27

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/05/27

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/05/27

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/05/27

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/05/26

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/04/30

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/16

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/04/09

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/18

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/24

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals